It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The first feature concerns the apparent fact that Dr, Kent Brantly shares the same blood type, for purposes of plasma transfusion, with three U.S. citizens purportedly stricken with Ebola who are tightly connected with U.S. soil: Dr. Nick Sacra, NBC cameraman Ashoka Mukpo, and nurse Nina Pham. Dr. Angela Hewitt remarked upon the Brantly’s second successive match, which was with Mukpo: “it’s not a likely scenario that he would again have the same blood type,” said Hewlett. “We are incredibly grateful that Dr. Brantly would take the time to do this, not once, but twice.” To the two matches mentioned by Hewitt we must now add, as mentioned just now, the Pham match.
On this first feature, we are going to do something that innumerate, propagandist Axis MSM mouthpieces unwilling and in most cases unable to do, which is compute the probability that Brantly’s blood type matched, for plasma transfusion purposes, the blood type of Sacra, Mukpo, and Pham. That probability, it turns out, is very low indeed.
Compatible Plasma Donor
O, AB, A, B
The second suspect feature of the MSM Ebola narrative surrounds the Pham Ebola case in particular. While it may sound bombastic, the brute fact is that right now—again on formal probabilistic grounds but this time together with contextual evidence—there is very little reason to believe that Pham in fact contracted Ebola. As you will see, this is very easily demonstrated.
Also in connection with the prior probability issue, interested readers may want to examine an academic article entitled “Incubation Period of Ebola Hemorrhagic Virus Subtype Zaire.” There, we find evidence that even strong contacts with the Ebola-infected can leave substantial probabilities that infection will be avoided—even over time periods as long as a week. True, that might help explain why Dallas apartment Duncan contacts have not contracted Ebola, and yet, with at least 70 health care workers supposedly exposed and no additional Ebola diagnoses as of now, plentiful questions remain.
In view of all of the above, is it beyond all reason to suppose that Pham, and conceivably even Brantly, have been duped—along with much of the rest of the “bioterrorized” world—at least with respect to purported U.S. citizen, U.S. soil Ebola cases?
Drew's death was not the result of his having been refused medical care because of his skin color
One key U.S. driven lie has to do with the Western MSM’s insistence that nobody of any repute believes that Ebola might be airborne. On this issue, the Public Health Agency of Canada remarks:
In the laboratory, infection through small-particle aerosols has been demonstrated in primates, and airborne spread among humans is strongly suspected, although it has not yet been conclusively demonstrated (1, 6, 13). The importance of this route of transmission is not clear. Poor hygienic conditions can aid the spread of the virus.
A few scientific studies expressing concern about the airborne possibility are cited in this article, and other such studies are not hard to find.
The second lie really is a lie of nondisclosure, and concerns the reality that the MSM has not told us that we are dealing with a biologically distinct form of Ebola that has never been seen before.
So, consider the following disconcerting information appearing in the New England Journal of Medicine in April 2014 regarding the current West African, Guinean outbreak of Ebola:
Phylogenetic analysis of the full-length sequences established a separate clade for the Guinean EBOV strain in sister relationship with other known EBOV strains. This suggests that the EBOV strain from Guinea has evolved in parallel with the strains from the Democratic Republic of Congo and Gabon from a recent ancestor and has not been introduced from the latter countries into Guinea. Potential reservoirs of EBOV, fruit bats of the species Hypsignathusmonstrosus, Epomopsfranqueti, & Myonycteristorquata, are present in large parts of West Africa.18 It is possible that EBOV has circulated undetected in this region for some time. The emergence of the virus in Guinea highlights the risk of EBOV outbreaks in the whole West African subregion.
Now the third U.S. Ebola lie: In a Matt Drudge-linked article entitled “The Federal Government’s Inconsistent Ebola Story”, we find that the U.S. government is telling two completely inconsistent stories regarding the circumstances surrounding delivery of MappPharmaceuticals’ magic ZMapp Ebola drug to Dr. Kent Brantly and Nancy Writebol. Thus, we have:
According to the CDC, it was Samaritan’s Purse, the private humanitarian organization that employs Dr. Brantley, who reached out to them in an attempt to find an experimental Ebola drug. The CDC says it passed Samaritan’s Purse along to NIH, who referred them to contacts within Mapp.
“This experimental treatment was arranged privately by Samaritan’s Purse,” the CDC said. “Samaritan’s Purse contacted the Centers for Disease Control and Prevention (CDC), who referred them to the National Institutes of Health (NIH). NIH was able to provide the organization with the appropriate contacts at the private company developing this treatment. The NIH was not involved with procuring, transporting, approving, or administering the experimental treatments.”
The New York Times first reported this version of events on Aug. 6, and the statement was posted on the CDC’s website a few days later,where it remains.
Dr. Kent Brantly told ABC News today that his blood type is A+, while Duncan's family has said his blood type was B+, making them incompatible for a transfusion of whole blood or plasma. Blood transfusions from someone who successfully battled the virus are believed to possibly be beneficial to Ebola patients.